World News: 12:30 GMT Wednesday 12th June 2019. [Strongbridge Biopharma plc via Globe Newswire via SPi World News]
DUBLIN, Ireland and TREVOSE, Pa., June 12, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will present at the 2019 JMP Securities Life Sciences Conference taking place June 19-20 at the St. Regis Hotel in New York, NY.
Matthew Pauls, president and chief executive officer of Strongbridge Biopharma, will provide a corporate overview on Wednesday, June 19 at 11:00am E.T. The presentation will be webcast live and archived on the “Events & Presentations” page in the investor section of the Company’s website at .
Globe Newswire: 12:30 GMT Wednesday 12th June 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.